SOLACI Celebrated 25 Years during SOLACI-SBHCI 2019

During the opening ceremony of SOLACI-SBHCI 2019, the president of the Latin American Society of Interventional Cardiology, Dr. José Luis Leiva Pons, celebrated the first 25 years of our society’s life together with some of the greatest international personalities in our field (Dr. Gregg Stone, Dr. Martin Leon and Dr. Patrick Serruys) and former SOLACI presidents like Dr. Expedito Ribeiro and Dr. Alexandre Abizaid.

PH: Antônio More / MorePress

Dr. Leiva Pons remembered the start of our society with the creation of GLACI (the Latin American Group of Interventional Cardiology), back on June 26, 1993, and reminded us of the fundamental contributions of Drs. Hugo Londero and Alberto Sampaolesi (Argentina), J. Eduardo Sousa and Costantino Costantini (Brazil), Eugenio Marchant, Alfredo Ramírez, Hernán Chamorro and Hector Ducci (Chile), Alfredo Buitrón and Walter Espasandín (Uruguay), José Condado (Venezuela), and Marco Antonio Martínez Ríos, Manuel Gil, Jorge Gaspar, Ernesto BanHayasi, Ramón Villavicencio and Marco A. Peña Duque (México).

PH: Antônio More / MorePress

At the same time, Dr. Leiva evoked what was the official foundation of our society on November 15, 1994, during the American Heart Association’s annual meeting in Dallas, Texas, and the expansion and evolution of SOLACI in the hands of great presidents like Drs. Alfredo Martínez Ríos, Hugo Londero, J. Eduardo Sousa, Alberto Suárez, Jorge Belardi, Eugenio Marchant, Expedito Ribeiro, Irving Peña, Fausto Buitrón, Ernesto Ban Hayasi, Daniel Berrocal, Alexandre Abizaid, Darío Echeverri, Oscar Méndiz, Jamil Abdalla Saad and Ricardo Lluberas.

As corollary, Dr. Leiva Pons concluded his speech by vindicating the great heroes of SOLACI’s: the expert international physicians, founding partners and members, nurses and technicians, the industry and their support, and SOLACI’s office. Drs. Gregg Stone, Martin Leon and Patrick Serruys followed with a few words.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...

V International Course on Cardiovascular Interventionism – SOLACI Scientific Endorsement

The Latin American Society of Interventional Cardiology (SOLACI) proudly grants its scientific endorsement to the V International Course on Cardiovascular Interventionism, an important academic...

Guatemala Sessions 2026 – Young Interventional Cardiologists Contest – Submit Your Case

The call for applications to participate in the Young Interventional Cardiologists Competition at the Guatemala 2026 Regional Sessions is now open. The event will...

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...